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Abstract

Author Manuscript

The aggregation of the 37-amino acid polypeptide islet amyloid polypeptide (IAPP, amylin), as
either insoluble amyloid or as small oligomers, appears to play a direct role in the death of
pancreatic β-islet cells in type 2 diabetes. It is believed that inhibiting the aggregation of IAPP
may slow down, if not prevent entirely, the progression of this disease. Extracts of thirteen
different common fruits were analyzed for their ability to prevent the aggregation of
amyloidogenic IAPP. Thioflavin T binding, immuno-detection and circular dichroism assays were
performed to test the in vitro inhibitory potential of each extract. Atomic force microscopy was
used to visualize the formation of amyloid fibrils with and without each fruit extract. Finally,
extracts were tested for their ability to protect living mammalian cells from the toxic effects of
amyloid IAPP. Several fruits showed substantial ability to inhibit IAPP aggregation and protect
living cells from toxic IAPP amyloid.
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1. Introduction

Author Manuscript

The natural products isolated from fruit extracts have been associated with many positive
health benefits. These health benefits span a variety of fields, showing beneficial
functionalities for anti-cancer (Chia-Hung, Chi-Chou, Hsu, Kao, & Wang, 2015; Olsson,
Gustavsson, Andersson, Nilsson, & Duan, 2004; Zunino, Zhang, Seeram, & Storms, 2010),
anti-aging (Shukitt-Hale, Carey, Jenkins, Rabin, & Joseph, 2007), and anti-obesity
(Chaudhary et al., 2014) to name a few. Previous studies have indicated that several
individual fruits are capable of inhibiting the formation of protein aggregates associated with
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amyloid-linked diseases, such as Alzheimer’s disease and type 2 diabetes (Li, Jang, Sun, &
Surh, 2004; Park; Zhu, Bickford, Sanberg, Giunta, & Tan, 2008). However, to the best of
our knowledge, no study has been performed to directly compare the efficacy of multiple
fruits, spanning several fruit families, at inhibiting amyloid formation. In this work, thirteen
common fruits were analyzed for their ability to prevent the aggregation of amyloidogenic
islet amyloid polypeptide (IAPP), the amyloid protein associated with the progression of
type 2 diabetes. The natural propensity of IAPP to aggregate into toxic amyloidogenic
species is believed to occur in a similar fashion as other amyloidogenic proteins, such as
Aβ42 in Alzheimer’s disease and α-synuclein in Parkinson’s disease. Fruit extracts capable
of inhibiting the aggregation of IAPP, considered one of the most amyloidogenic protein
known (Cao, Abedini, & Raleigh, 2013a), are likely to function as inhibitors of other
amyloid proteins as well (Montane, Klimek-Abercrombie, Potter, Westwell-Roper, &
Verchere, 2012).

Author Manuscript

The incidence of type 2 diabetes within developed nations continues to increase. The
American Diabetes Association estimates that 25.8 million Americans have diabetes
(approximately 8.3% of the population ("Type 2 Diabetes Facts and Figures," 2011)), with
nearly 2 million new cases diagnosed each year. While obesity is a factor in the
development of type 2 diabetes, over 70% of obese people do not have diabetes, suggesting
that other factors influence the progression of this disease (cdc-national center for health
statistics, National Data Brief, No. 82, Jan 2012) (Ogden, Carroll, Kit, & Flegal; Ogden,
Carroll, Kit, & Flegal).

Author Manuscript
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One possible factor linked to the progression of type 2 diabetes is the aggregation of the
amyloidogenic peptide islet amyloid polypeptide (IAPP) (Montane et al., 2012). This 37amino acid polypeptide is co-secreted from pancreatic β-islet cells with insulin. During the
progression of type 2 diabetes, IAPP aggregates into a variety of different amyloidogenic
states (Abedini & Schmidt, 2013; Apostolidou, Jayasinghe, & Langen, 2008; Hull,
Westermark, Westermark, & Kahn, 2004; Kahn, Andrikopoulos, & Verchere, 1999). While
the exact structure and nature of these aggregates remains to be determined, it is clear that
some of these aggregates are highly toxic to cells (Andrews, Inayathullah, Jayakumar, &
Malar, 2009; Cao et al., 2013b; Nanga, Brender, Xu, Veglia, & Ramamoorthy, 2008). For
example, Eisenberg and coworkers recently suggested that the most toxic form of IAPP may
self-assemble into a cylindrin structure (Laganowsky et al., 2012; Liu et al.). These
oligomeric structures seem to be the toxic form of the amyloid proteins. While the exact
mechanism of toxicity remains unknown, two theories suggest that the oligomers either (1)
form pores in the cellular membranes or (2) disrupt cellular membranes through membrane
fragmentation (Brender, Salamekh, & Ramamoorthy, 2012). Ramamoorthy and coworkers
have used NMR to solve the structures of several human and rat IAPP peptides under a
variety of conditions, including within micelles (Brender, Durr, Heyl, Budarapu, &
Ramamoorthy, 2007; Brender et al., 2008; Nanga et al., 2009; 2008; Soong, Brender,
Macdonald, & Ramamoorthy, 2009). Regardless of the exact structure of the IAPP
aggregates, their toxicity to cells may be the root cause of the progression of type 2 diabetes
(Ritzel, Meier, Lin, Veldhuis, & Butler, 2007). Likewise, the toxicity of these aggregates
appears to preclude the use of β-cell transplantation therapies (Potter et al.). The possibility
exists that preventing the formation of toxic IAPP aggregates could slow, if not prevent
J Funct Foods. Author manuscript; available in PMC 2016 February 16.
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entirely, the progression of type 2 diabetes. Additionally, inhibiting the formation of these
toxic aggregates may make future pancreatic β-cell transplantation therapies a reality.
The fruits described in this study were chosen for analysis because of their abundant
availability within the United States and their distribution across several different fruit
families. Because of the considerable levels of carbohydrates within these fruits (a fact that
prevents many diabetic patients from ingesting large amounts of these fruits on a regular
basis), we chose an extraction method that removed over 99% of the carbohydrates from the
samples. The resulting fruit extracts were tested for their in vitro ability to prevent the
formation of amyloid aggregates and their ex vivo ability to protect living mammalian cells
from toxic IAPP amyloid.

2. Materials and Methods
Author Manuscript

2.1 Preparation of Fruit Extracts
For each individual whole fruit, 100 grams was ground using a mortar and pestle in the
presence of 100 mL of ethyl acetate. The resulting slurry was filtered and the ethyl acetate
layer isolated. The ethyl acetate was removed via speed vacuum yielding approximately 8
aliquots of dehydrated solid extracts. These dehydrated extracts were stored at −20°C.
Extracts were rehydrated by resuspending each aliquot in 150 µL 20 mM tris buffer pH 7.40
(standard solution) or 1.50 mL of the same buffer (yielding samples 10× diluted).
2.2 Preparation of IAPP stock solutions

Author Manuscript

IAPP stock solutions were prepared by dissolving 1 mg of synthetic amylin (Anaspec Corp.
Fremont, CA, USA) in 8 mL of hexafluorisopropanol (HFIP, Sigma Aldrich, St. Louis, MO,
USA). To fully disaggregate the IAPP, the sample was placed in a sonicating water bath for
5 min. This stock solution was stored at −80°C for up to two months.
2.3 Thioflavin T binding (ThT) assays
HFIP was removed from the IAPP stock solution under speed-vacuum. The dry IAPP
sample was resuspended in 20 mM tris buffer pH 7.40 containing each individual fruit
extract. The final in-solution concentration of IAPP was 106 µM. Aggregation was initiated
by incubating samples at 37°C with shaking (200 rpm). At designated time points, a 17 µL
aliquot of each sample was removed and mixed with 663 µL of 50.0 µM thioflavin T in 20
mM Tris buffer pH 7.40. The IAPP/thioflavin T mixture was incubated at room temperature
in the dark for 2 min before recording the thioflavin T fluorescence emission spectrum
(Ex450nm) using a Hitatchi F-7000 fluorescence spectrophotometer.

Author Manuscript

2.4 Atomic Force Microscopy (AFM)
Synthetic IAPP was prepared as described above and incubated with shaking in the presence
of individual fruit extracts. After 40 min of incubation, 20 µL of each sample were deposited
onto freshly cleaved mica. After incubation at room temperature for 5 min, the mica was
washed with 200 µL sterile-filtered water and allowed to air dry. The samples were scanned
using an MFP-3D atomic force microscope (Asylum Research, Santa Barbara, CA, USA) set
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on A/C mode and a 240 µm silicon cantilever (Olympus Corporation of the Americas, PA,
USA). Images shown are the raw data with no flattening.
2.5 Circular Dichroism (CD)
CD spectroscopy was performed using a J-815 CD Spectrometer (Jasco Inc, Easton, MD,
USA) with quartz cuvettes of 1 mm pathlength. Samples were scanned from 190 nm to 250
nm. In order to reduce interference by the fruit extracts, 10× diluted fruit samples were
mixed with IAPP. The final in-solution IAPP concentration was 76.8 µM. IAPP, in the
presence and absence of each fruit sample, was incubated for 40 min at 37°C with shaking
(200 rpm). These rigorous conditions reproducibly yielded IAPP fibrils (visible with Atomic
Force Microscopy) with CD spectra having a single minimum at 218 nm.
2.6 Immunoblot dot test

Author Manuscript
Author Manuscript

Samples of IAPP were incubated with individual fruit extracts as described in the thioflavin
T assay above. At designated time intervals, 2uL of each IAPP sample (with or without a
fruit extract) were placed on a nitrocellulose membrane. The resulting membrane was
allowed to air dry before blocking in 2.5% BSA in TBST buffer for 1 h at room temperature.
After blocking, the membrane was cut in half, with one half probed with Millipore’s A11
antibody (AB9234) and the other half probed with Millipore’s Fibril OC antibody (AB2286)
(Millipore, Billerica, MA, USA). Both antibodies were applied at a 1:1000 (v,v) dilution for
1 h at room temperature. The membranes were washed three times for 5 min each with
TBST buffer. The membranes were probed with donkey anti-rabbit secondary antibody
conjugated to HRP (1:2000 v,v) for 1 h at room temperature. The membranes were washed
three times with TBST buffer. A final wash with TBS for 5 min was conducted before
developing using GE’s Amersham ECL reagent with a 10 min exposure time. Images were
taken using the Bio-Rad Imaging System.
2.7 HeLa cell rescue

Author Manuscript

HeLa cells were incubated with 15 µM of synthetic IAPP prepared as described above.
Equal amounts of HeLa cells were plated in triplicate and incubated overnight in 96-well
plates. After 24 h, F-12K media with phenol red was replaced by DMEM/F12 (1:1 v,v)
without phenol red. Hexafluoroisopropanol (HFIP) was evaporated from IAPP using a
centrivap concentrator (LabOnco). IAPP was re-suspended in DMEM/F12 media, the pellets
were then mixed into the media by vortexing (Vortex Genie Mixer) for 2 min. Stock
solutions of each fruit extract were diluted with 25 mM Tris Buffer (pH 7.4) and added to
the appropriate wells. The treated cells were incubated for 22 h at 37°C. Post-incubation,
MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-tetrazolium bromide) was added into each
well and incubated at 37°C for 2 h. Formazan crystals, formed on the bottom of the wells,
were re-suspended in a solubilization buffer (20% SDS and 50% dimethylformamide). The
absorbance in each well was taken at 570 nm using a BioRad 550 microplate reader. HeLa
cells and media were obtained from ATCC. All incubations took place in a water jacketed
incubator in 5% carbon dioxide at 37°C (Shell Lab). The average percentage of cell viability
was calculated for each of the conditions.

J Funct Foods. Author manuscript; available in PMC 2016 February 16.

Kao et al.

Page 5

Author Manuscript

3. Results
The ethyl-acetate extracts of several common fruits were analyzed to identify those having
the greatest potential for inhibiting the aggregation of amyloidogenic IAPP. Each fruit
extract was initially analyzed for its ability to prevent thioflavin-T (ThT) binding to IAPP
(Figure 1). ThT binding is a facile method for detecting and quantifying amyloid formation.
ThT shows little fluorescence emission when solubilized in an aqueous solution. However,
ThT fluorescence increases in a concentration-dependent manner when in the presence of
amyloid (LeVine, 1993).

Author Manuscript

IAPP is believed to form a variety of different amyloidogenic aggregates with varying
degrees of cellular toxicity (Andrews et al., 2009; Gazit, 2005; Haataja, Gurlo, Huang, &
Butler, 2008). IAPP with and without each fruit extract was probed with the A11 antibody
and the Fibril OC antibody (Figure 2). The A11 antibody is an anti-oligomer antibody that
specifically binds to small soluble oligomers, believed to be the more toxic form of IAPP
amyloid. The Fibril OC antibody is an anti-fibril antibody that specifically binds to the
fibrillar form of IAPP. Dark spots on the immuno-detection assays indicated the presence of
the amyloidogenic species, while colorless spots and white spots both indicated the absence
of amyloidogenic species.

Author Manuscript

A more direct method for assessing amyloid inhibition potential is through the visualization
of amyloidogenic fibrils. Atomic force microscopy (AFM) was used to visualize the
formation of amyloid fibrils in the presence and absence of each fruit extract (Figures 3 and
4). The use of AFM allows for a direct detection of an amyloidogenic species in the
presence and absence of each fruit extract. Likewise, circular dichroism (CD) spectroscopy
was used to detect the conversion of unstructured IAPP peptides into the β-sheet-rich
amyloidogenic species of IAPP (Figure 5). Finally, to test the ability of each fruit extract to
protect living cells from IAPP, the MTT assay was performed using HeLa cells (Figure 6).
The MTT levels of HeLa cells alone were set as 100%. The addition of IAPP (labeled as
amylin) to the HeLa cells decreased the cell viability to 67% in less than 24 h. The 25mm
Tris Buffer was tested to ensure that there was no conflict with cell viability.

4. Discussion
4.1 Thioflavin T binding

Author Manuscript

The time course data for ThT binding to IAPP amyloid (Figure 1) indicated that most of the
fruit samples were capable of slowing and/or preventing the aggregation of IAPP under
rigorous aggregate-forming conditions. The fruits showing the least inhibitory potential
according to the ThT results were banana, pineapple, and lemon. The remaining fruit
extracts showed significant inhibitory potential. Th T binding by amyloid is a useful
diagnostic for gauging the ability of a potential therapeutic to prevent amyloid formation.
However, it is possible that the lack of ThT fluorescence may be due to inhibition of ThT
binding to the amyloid, rather than preventing amyloid formation (this has been
experimentally observed in the case of EGCG competing with ThT for binding to IAPP)
(Suzuki, Brender, Hartman, Ramamoorthy, & Marsh, 2012). For this reason, it is important
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to conduct additional experiments to identify true amyloid inhibitors and potential
therapeutic agents.
4.2 Immuno-detection
We chose to perform immuno-detection assays to identify the amyloid species being
inhibited by each fruit extract. The results (Figure 2) indicated that several fruits (banana,
tomato, mango and nectarine) had little inhibitory potential, while the remaining fruits
displayed some ability to prevent IAPP amyloid formation. These results also suggest that
both IAPP oligomers and fibrils were inhibited in the presence of most of the fruit extracts.
The fruit extracts showing the greatest inhibitory potential from these immuno-detection
assays were grape, strawberry, pomegranate and raspberry (all of which were strong
inhibitors according to the ThT results in Figure 1).

Author Manuscript

4.3 Atomic force microscopy

Author Manuscript

AFM, a direct test that allows the visualization of amyloidogenic fibrils, provided evidence
suggesting that some fruit extracts were stronger inhibitors than others. Due to the fact that
significant amounts of fibrils were observed, several fruit extracts (banana, kiwi, lemon,
mango, nectarine, strawberry, and tomato) showed little ability to inhibit IAPP fibril
formation (Figure 3). IAPP fibrils were found on every AFM sample in the presence of these
non-inhibiting fruits. The remaining fruit extracts (blackberry, blueberry, grape, pineapple,
pomegranate, and raspberry) showed significant ability to inhibit fibril formation (Figure 4)
compared to IAPP in the absence of inhibitors. In every sample tested, high concentrations
of the fruit extracts prevented fibril formation (Figure 4). The strongest inhibitors of fibril
formation were the pomegranate, raspberry and blueberry extracts. When diluted 100×,
these three extracts still prevented fibril formation in all samples tested. Whereas, extracts of
the other inhibitor fruits (blackberry, grape and pineapple) began to lose potency after a 10×
dilution of the extract (minor amounts of fibrils could be seen – data not shown).
4.4 Circular Dichroism

Author Manuscript

Like most amyloidogenic proteins, it is believed that the conversion of IAPP to an
amyloidogenic state involves the formation of β-sheet secondary structure. It is well
documented that the fibrillar form of IAPP forms a cross β-structure perpendicular to the
axis of the fibril. This conversion from unstructured peptide to β-sheet was monitored via
circular dichroism spectroscopy (CD). As IAPP adopts the β-sheet structure indicative of
amyloidogenic aggregates, the CD signal displays a local minima at 218 nm. Fruit extracts
found to prevent the conversion of IAPP into β-sheet rich structures are shown in Figure 5A.
The CD signal of IAPP after incubation in the presence of inhibitory extracts (blackberry,
blueberry, lemon, mango, nectarine, raspberry and tomato) resembles the CD signal of IAPP
prior to incubation (data not shown). The fruit extracts of banana and strawberry (Figure 5B)
showed little ability to prevent the conversion to β-sheet rich structures. Several fruit
extracts (pomegranate, pineapple, grape, and kiwi) possessed CD-active extracts that
interfered with the IAPP signal.
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To test the potential of fruit extracts to protect living cells from toxic IAPP aggregates, the
MTT assay was performed using HeLa cells (Figure 6). The MTT assay, which quantitates
the oxidative capacity of HeLa cells after treatment with the respective fruit extract and/or
IAPP, indicated that certain fruit extracts had greater protective qualities compared to others.
The addition of nectarine, raspberry, and pineapple significantly rescued the HeLa cells (p <
0.05, t-test) from the toxic effects of IAPP. Tomato and banana extracts demonstrated the
least potential for rescuing cells from IAPP toxicity. Several fruit extracts (strawberry,
blackberry, lemon and kiwi) seemed to hinder cellular viability even in the absence of IAPP.
5. Conclusions

Author Manuscript

This comparative study evaluated the ability of common fruit extracts to inhibit the
aggregation of IAPP into toxic amyloid species. These results indicate that many fruits
possess the potential to inhibit IAPP aggregation, but several fruits were found to have
significantly greater inhibitory activity. The fruit extracts with the greatest overall ability to
prevent amyloid aggregation and simultaneously protect living cells from IAPP toxicity
were the berries, raspberry and blueberry. Also showing substantial inhibitory activity were
the pomegranate and grape extracts. Conversely, the banana and kiwi extracts showed
virtually no inhibitory activity. The remaining fruits tested possessed moderate activity,
showing mixed levels of aggregation inhibition in the various experiments performed.

Author Manuscript

The use of ethyl acetate as the extraction solvent yielded two beneficial outcomes. First,
over 99% of the total carbohydrate of each extract remained within the aqueous phase (data
not shown). Therefore, this choice of extraction solvent removed over 99% of the total sugar
content. Because individuals suffering from type 2 diabetes must control their sugar intake,
this extraction process could be used to produce a therapeutically viable form of each fruit.
Second, the use of ethyl acetate pulls out and concentrates polyhydroxylated phenols and
catechins, classes of compounds believed to possess a range of positive health benefits,
including inhibition of amyloid formation.

Author Manuscript

From these results, we believe it is unlikely that the inhibitory component(s) for each fruit
extract are the same. In our studies, the extracts from raspberry, blueberry and blackberry all
performed well and were considered strong inhibitors of amyloid formation. Both raspberry
and blackberry contain a substantial amount of flavanols such as EGCG, a known inhibitor
of IAPP aggregation (Cao & Raleigh, 2012; Tang, 2007). Conversely, blueberry contains
very little EGCG and flavanol content, yet was found to be an equally good inhibitor
compared to raspberry and blackberry. Likewise, the amyloid inhibitory potential of each
fruit extract was not necessarily linked to the anti-oxidant content of each fruit. Grapes, one
of the strongest inhibitors of IAPP aggregation, have roughly the same antioxidant content
as nectarines, bananas, and kiwis, the worst performers in this study.
The folding (or misfolding) process proteins undergo in their transition into toxic amyloid is
not yet fully understood. However, it is believed that despite their differences in amino acid
sequences and compositions, the majority of amyloid proteins undergo a similar aggregation
pathway that leads to structurally similar amyloidogenic aggregates. Because of this, it is

J Funct Foods. Author manuscript; available in PMC 2016 February 16.

Kao et al.

Page 8

Author Manuscript

possible that substances capable of inhibiting the aggregation of one amyloid protein may
also be capable of inhibiting others. Because IAPP is considered to be one of the most
amyloidogenic proteins known, substances found to inhibit this amyloid protein may be
potential therapeutics for other amyloid proteins, such as Aβ42 aggregation in Alzheimer’s
disease or α-synuclein in Parkinson’s disease (Fox et al., 2010).
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Highlights
•

Comparative study to identify fruits having the greatest potential for preventing
amyloid.

•

Extraction system described for producing bioactive samples lacking
carbohydrates.

•

Several fruit extracts protected living cells from high doses of toxic IAPP.

Author Manuscript
Author Manuscript
Author Manuscript
J Funct Foods. Author manuscript; available in PMC 2016 February 16.

Kao et al.

Page 12

Author Manuscript
Author Manuscript
Figure 1.
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Thioflavin T fluorescence of IAPP alone and IAPP in the presence of each fruit extract.
Fluorescence was measured with an excitation wavelength of 450 nm and an emission
wavelength of 488 nm. The solution concentration of IAPP was 106 µM for each sample.
Data is the average of at least three data sets.
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Figure 2.

Immunoblot dot test. Samples containing IAPP alone or IAPP with each fruit extract were
incubated at 37°C with shaking (200 rpm). 2 µL of each sample was dotted onto
nitrocellulose membrane and probed with A11 antibody (top panels) or Fibril OC antibody
(bottom panels). Dark spots indicate where the amyloid-binding antibodies detected amyloid
deposits. Blank and light spots indicate where amyloid was not present.
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Figure 3.

Atomic force microsope images of fruits showing modest to negligible ability to inhibit
IAPP fibril formation. a) IAPP alone b) banana c) kiwi d) lemon e) mango f) nectarine g)
strawberry h) tomato.
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Figure 4.

Atomic force microsope images of fruits showing significant ability to inhibit IAPP fibril
formation. a) IAPP alone b) blackberry c) blueberry d) grape e) pineapple f) pomegranate g)
raspberry.
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Figure 5.

Circular Dichroism of IAPP after 40 minute incubation. (a) Fruits showing significant
ability to prevent the conversion of IAPP to β-sheet conformation (b) Fruits showing
negligible ability to prevent the conversion of IAPP to β-sheet conformation and (c) Fruits
with UV-active extracts that interfered with monitoring of the IAPP β-sheet transition.
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Figure 6.
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Relative cell viability (%) in the presence of IAPP and/or fruit extracts. The “Media” and
“Buffer” samples represent cell viability in the presence of media alone and media with Tris
Buffer respectively (no IAPP was included in these samples). “Amylin” shows the effect of
IAPP on cell viability. Grey bars indicate samples with IAPP and the specified fruit extract.
White bars correspond to the effect of each individual fruit extract alone (with no IAPP
present) on the viability of cells.
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